<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02926300</url>
  </required_header>
  <id_info>
    <org_study_id>KSTHD_FURESTEM-CD-EXT</org_study_id>
    <nct_id>NCT02926300</nct_id>
  </id_info>
  <brief_title>Long-term Safety and Efficacy of FURESTEM-CD Inj. in Patients With Moderately Active Crohn's Disease(CD)</brief_title>
  <official_title>Extension Study, An Open-labelled, Multi Center, Comparative Phase I/IIa Clinical Trials to Evaluate the Efficacy and Safety of FURESTEM-CD Inj. in Patients With Moderately Active Crohn's Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kang Stem Biotech Co., Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kang Stem Biotech Co., Ltd.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this clinical trial is to evaluate long-term safety and efficacy in patients
      who has history of FURESTEM-CD injection at least once.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is an extended study of KSTHD_FURESTEM-CD phase 1 / 2a clinical trials in patients
      with moderate active Crohn's disease who had received at least once a FURESTEM-CD injection.
      The purpose of this clinical trial is to evaluate long-term safety and efficacy in patients
      for approximately 36 months (144 weeks).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2015</start_date>
  <completion_date type="Anticipated">November 2021</completion_date>
  <primary_completion_date type="Anticipated">October 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>all kinds of adverse events which occur during the clinical sutdy</measure>
    <time_frame>114 weeks</time_frame>
    <description>Safety outcome</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>ratio of patients who is applicable to CDAI&lt;150</measure>
    <time_frame>114 weeks</time_frame>
    <description>Efficacy outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ratio of patients who reduce CDAI over 70 as contrasted witd baseline(V7)</measure>
    <time_frame>114 weeks</time_frame>
    <description>Efficacy outcome</description>
  </secondary_outcome>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Crohn's Disease</condition>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>stem cells</intervention_name>
    <description>IV infusion</description>
    <other_name>FURESTEM-CD Inj.</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Gender: Both Age Limits: 19years to 70years Healthy Volunteers?: No.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients who has history of FURESTEM-CD Inj. injection at least once.

          -  patients who understand and voluntarily sign an informed consent form.

        Exclusion Criteria:

          -  any other condition which the Principle Investigator judges would make subject
             unsuitable for study participation.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Suk-kyun Yang</last_name>
    <role>Principal Investigator</role>
    <affiliation>Asan Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Eun-ji Kang</last_name>
    <email>ejkang@kangstem.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Inje University Haeundae Paik Hospital</name>
      <address>
        <city>Busan</city>
        <zip>48108</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tae-oh Kim</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Yeungnam University Medical Center</name>
      <address>
        <city>Daegu</city>
        <zip>42415</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Byung-Ik Jang</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Seoul National Universtiy Bundang Hospital</name>
      <address>
        <city>Seongnam-si</city>
        <zip>13620</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hyuk Yoon</last_name>
    </contact>
    <investigator>
      <last_name>Hyuk Yoon</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Severance Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>03722</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jae-hee Cheon</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Asan Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>138-736</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Su-jung Kim</last_name>
    </contact>
    <contact_backup>
      <last_name>Ji-young Park</last_name>
    </contact_backup>
    <investigator>
      <last_name>Suk-kyun Yang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Soeul National University Hospital</name>
      <address>
        <city>Soeul</city>
        <zip>110-7441</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jong-pil Im</last_name>
    </contact>
    <investigator>
      <last_name>Jong-pil Im</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Catholic University of Korea, St. Vincent`S Hospital.</name>
      <address>
        <city>Suwon-si</city>
        <zip>16247</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kang-moon Lee</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 11, 2015</study_first_submitted>
  <study_first_submitted_qc>October 5, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 6, 2016</study_first_posted>
  <last_update_submitted>September 5, 2017</last_update_submitted>
  <last_update_submitted_qc>September 5, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 6, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>crohn's disease</keyword>
  <keyword>stem cell therapy</keyword>
  <keyword>inflammatory bowel disease</keyword>
  <keyword>hUCB-MSC</keyword>
  <keyword>UCB-MSC</keyword>
  <keyword>Umbilical cord Blood</keyword>
  <keyword>Rheumatoid Arthritis</keyword>
  <keyword>RA</keyword>
  <keyword>Stem cell</keyword>
  <keyword>Cell therapy</keyword>
  <keyword>Furestem</keyword>
  <keyword>Mesenchymal stem cell</keyword>
  <keyword>MSC</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Crohn Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

